Pro Analysis Available: Full unrolled post citations, institutional 13F filing matrix, and real-time sentiment alerts for $CVS are available with SpikePanel Pro.
IRA pricing changes create revenue headwinds, but company maintains profitability through distribution agreements
D1 -0.1% · +5d -5.3%
›2 waves of this story
2026-09-10 Executives reiterate cautious view on healthcare cost trends while citing improved momentum across insurance, pharmacy, and balance-sheet priorities
2026-09-17 IRA pricing changes create revenue headwinds, but company maintains profitability through distribution agreements
11 earlier events›
AnalystBull
Baird Grows CVS Stake, Reinforcing Long-Term Value
Baird ups stake 4% to 10,059 shares, adding institutional vote of confidence.
D1 +3.9% · +5d -2.3%
›2 waves of this story
2026-09-01 Analyst bullish on management, stock rallies 3.4%-3.7%
2026-09-11 Baird ups stake 4% to 10,059 shares, adding institutional vote of confidence.
CompanyBull
CVS Pharmacy & Consumer Wellness Q2 Operating Income Up 10.2%
Higher script volumes and improved margins lift segment operating income to $1.48B.
D1 -0.1% · +5d -5.3%
›2 waves of this story
2026-09-10 CVS comments on medical cost trends trigger sector-wide decline, affecting peers like UNH and OSCR
2026-09-10 Higher script volumes and improved margins lift segment operating income to $1.48B.
Product
Updated COVID-19 Vaccines Available at CVS Pharmacy and MinuteClinic Nationwide
Company announcement confirms 2026-2027 season vaccines in stores, appointments and walk-ins accepted
D1 +0.0% · +5d -2.6%
Product
CVS Rolls Out Seasonal Flu and Updated COVID-19 Vaccines at Stores and MinuteClinics
Extends prior flu vaccine event with new COVID-19 vaccine availability, broadening product offering
D1 -1.5% · +5d +4.6%
›2 waves of this story
2026-08-27 >60% consumers plan flu shots; expanded testing/treatment makes CVS a seasonal care hub
2026-09-03 Extends prior flu vaccine event with new COVID-19 vaccine availability, broadening product offering
CapitalBull
Allworth Financial Buys $3.5M Stake in CVS Health
Institutional buying signals long-term confidence, adding to recent earnings beat and raised guidance
D1 +1.2% · +5d -0.2%
8-K filing
8-K: Item 5.02, Item 7.01, Item 9.01
D1 +1.0% · +5d -2.1%
EarningsBull
CVS Q2 Earnings Surge, FY Outlook Raised, but Risks Remain
Health Care Benefits profitability drives EPS up over 40%, FY AOI outlook raised, but medical costs and Caremark risks persist.
D1 -5.1% · +5d -4.4%
›3 waves of this story
2026-08-05 All three business segments beat, with Aetna insurance unit improving, prompting a raised annual profit outlook.
IRA pricing changes create revenue headwinds, but company maintains profitability through distribution agreements
D1 -0.1% · +5d -5.3%
›2 waves of this story
2026-09-10 Executives reiterate cautious view on healthcare cost trends while citing improved momentum across insurance, pharmacy, and balance-sheet priorities
2026-09-17 IRA pricing changes create revenue headwinds, but company maintains profitability through distribution agreements
AnalystBull
Baird Grows CVS Stake, Reinforcing Long-Term Value
Baird ups stake 4% to 10,059 shares, adding institutional vote of confidence.
D1 +3.9% · +5d -2.3%
›2 waves of this story
2026-09-01 Analyst bullish on management, stock rallies 3.4%-3.7%
2026-09-11 Baird ups stake 4% to 10,059 shares, adding institutional vote of confidence.
CompanyBull
CVS Pharmacy & Consumer Wellness Q2 Operating Income Up 10.2%
Higher script volumes and improved margins lift segment operating income to $1.48B.
D1 -0.1% · +5d -5.3%
›2 waves of this story
2026-09-10 CVS comments on medical cost trends trigger sector-wide decline, affecting peers like UNH and OSCR
2026-09-10 Higher script volumes and improved margins lift segment operating income to $1.48B.
Product
Updated COVID-19 Vaccines Available at CVS Pharmacy and MinuteClinic Nationwide
Company announcement confirms 2026-2027 season vaccines in stores, appointments and walk-ins accepted
D1 +0.0% · +5d -2.6%
8 earlier events›
Product
CVS Rolls Out Seasonal Flu and Updated COVID-19 Vaccines at Stores and MinuteClinics
Extends prior flu vaccine event with new COVID-19 vaccine availability, broadening product offering
D1 -1.5% · +5d +4.6%
›2 waves of this story
2026-08-27 >60% consumers plan flu shots; expanded testing/treatment makes CVS a seasonal care hub
2026-09-03 Extends prior flu vaccine event with new COVID-19 vaccine availability, broadening product offering
CapitalBull
Allworth Financial Buys $3.5M Stake in CVS Health
Institutional buying signals long-term confidence, adding to recent earnings beat and raised guidance
D1 +1.2% · +5d -0.2%
8-K filing
8-K: Item 5.02, Item 7.01, Item 9.01
D1 +1.0% · +5d -2.1%
EarningsBull
CVS Q2 Earnings Surge, FY Outlook Raised, but Risks Remain
Health Care Benefits profitability drives EPS up over 40%, FY AOI outlook raised, but medical costs and Caremark risks persist.
D1 -5.1% · +5d -4.4%
›3 waves of this story
2026-08-05 All three business segments beat, with Aetna insurance unit improving, prompting a raised annual profit outlook.
